Free Trial

2,372 Shares in The Clorox Company $CLX Acquired by Leo Wealth LLC

Clorox logo with Consumer Staples background

Leo Wealth LLC acquired a new position in The Clorox Company (NYSE:CLX - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 2,372 shares of the company's stock, valued at approximately $285,000.

Other institutional investors have also recently bought and sold shares of the company. Simplicity Wealth LLC grew its holdings in Clorox by 157.3% during the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company's stock worth $2,199,000 after acquiring an additional 11,198 shares during the period. Raymond James Financial Inc. grew its holdings in Clorox by 15.6% during the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company's stock worth $39,747,000 after acquiring an additional 36,352 shares during the period. OneDigital Investment Advisors LLC acquired a new stake in Clorox during the 1st quarter worth $247,000. Brown Miller Wealth Management LLC acquired a new stake in Clorox during the 1st quarter worth $399,000. Finally, Roman Butler Fullerton & Co. acquired a new stake in Clorox during the 1st quarter worth $400,000. Institutional investors own 78.53% of the company's stock.

Clorox Price Performance

Shares of NYSE CLX opened at $120.14 on Friday. The firm has a market cap of $14.63 billion, a PE ratio of 18.43, a PEG ratio of 0.98 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The company has a fifty day moving average price of $122.21 and a 200 day moving average price of $128.79.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. Clorox's dividend payout ratio is presently 76.07%.

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of the company's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company's stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.57% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have commented on CLX shares. Bank of America lowered their target price on shares of Clorox from $135.00 to $125.00 and set a "neutral" rating for the company in a report on Wednesday. Zacks Research raised shares of Clorox from a "strong sell" rating to a "hold" rating in a report on Monday, September 29th. Citigroup decreased their price target on shares of Clorox from $135.00 to $130.00 and set a "neutral" rating for the company in a report on Wednesday. TD Cowen decreased their price target on shares of Clorox from $120.00 to $117.00 and set a "hold" rating for the company in a report on Wednesday, October 1st. Finally, Jefferies Financial Group decreased their price target on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a report on Thursday, June 26th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, Clorox presently has an average rating of "Reduce" and an average price target of $131.92.

Check Out Our Latest Report on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.